The US Food and Drug Administration (FDA) has granted de novo authorisation to Artera’s ArteraAI Prostate software.

The US Food and Drug Administration recently published an alert regarding Boston Scientific’s Watchman product, a heart ...

Reprieve Cardiovascular has closed an oversubscribed Series B financing round, raising $61m, for the trial of the Reprieve ...

Patient demonstrations, ongoing clinical trials and heavy investment signal that BCIs could be commercialised by 2030.

The rise of agentic artificial intelligence (AI) is liable to have multiple use cases for healthcare in patient-facing areas ...

Conformal has completed a Series D extension financing round, securing $32m to support its clinical trial of the CLAAS ...